期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CALCIFIED TISSUE INTERNATIONAL LetPub Score 6.6
50 ratings
Rate
Reputation 7.6 Influence 5.2 Speed 9.1 | ||||||||||||||||||||||||
期刊簡稱 | CALCIFIED TISSUE INT | ||||||||||||||||||||||||
ISSN | 0171-967X | ||||||||||||||||||||||||
E-ISSN | 1432-0827 | ||||||||||||||||||||||||
h-index | 106 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/223 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ctin | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer US | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1967 | ||||||||||||||||||||||||
每年文章數 | 109每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 34.44% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0171-967X%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CALCIFIED TISSUE INTERNATIONAL] 的評論 | 撰寫評論 |
作者: Amanda Tate 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-31 08:31:20 評論於 Review Speed: 24.0 | Submission Acceptance Rate: 95.0 Experience Share: This is a terrible magazine. I submitted my article and after half a month, it was still under review by the editor. I couldn't wait any longer so I sent an email to inquire about the status. They immediately rejected my submission, saying it did not meet the journal's requirements. I just want to ask, if it didn't meet the requirements, did you really need to wait a whole month? As soon as the author inquired via email, you immediately rejected the submission? This magazine is unreliable and always puts itself above the authors(0) 讚! | Amanda Tate |
作者: 通幽乐珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-26 23:33:50 評論於 It has been almost a month for me(0) 讚! | 通幽乐珍 |
作者: 一只雅歌呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-04 11:29:42 評論於 How long will it last?(0) 讚! | 一只雅歌呀 |
作者: 碧水冬荷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-07 08:02:19 評論於 How long will Reviewers Assigned last?(0) 讚! | 碧水冬荷 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:45:36 評論於 For example, experimental techniques such as PCR, Western blot, and the usage methods of some instruments(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:26:04 評論於 The general advice is to follow this order(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 21:01:55 評論於 Do methods have to be written in the order of results?(0) 讚! | Oswald Edie |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 23:34:47 評論於 What is the standard use method of the laboratory?(0) 讚! | 平原文波 |
作者: 雨巷少年喜云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-20 09:53:39 評論於 How much is the layout fee?(0) 讚! | 雨巷少年喜云 |
作者: 摔碑元斐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-27 13:52:52 評論於 Can you please talk about the convenience of AS from any aspect?(0) 讚! | 摔碑元斐 |
作者: 以冬少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-16 11:01:52 評論於 Review Speed: 2.0 | Submission Hit Rate: 75.0 Experience Sharing: Submitted on December 20, 2018, received revision comments on January 28, major revision, resubmitted on February 20, accepted on March 13(0) 讚! | 以冬少女 |
作者: 碧桃逸致 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-11 23:48:14 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: This journal is getting better and better. The impact factor has been rising in recent years, which is a good sign. I recently submitted two papers and received very valuable feedback from the reviewers(0) 讚! | 碧桃逸致 |
作者: Obal 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-01-11 17:11:47 評論於 This journal is getting better and better. The impact factor in recent years have been rising. It is a good proof. Recently, two of them have been submitted. The reviewers gave very good opinions (0) 讚! | Obal |
作者: Pearl Malachi 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-12-07 20:49:05 評論於 Is this magazine accepting reviews?(0) 讚! | Pearl Malachi |
作者: 北海哲玮 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-26 18:20:30 評論於 Do we need to provide the original data for this magazine?(0) 讚! | 北海哲玮 |
作者: 灵空凡海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-11 21:58:17 評論於 Is there a layout fee for this?(0) 讚! | 灵空凡海 |
作者: 宗室向凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-24 19:41:34 評論於 Do you charge a layout fee? How is it calculated?(0) 讚! | 宗室向凝 |
作者: 宗室向凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-17 14:08:28 評論於 How is the layout fee calculated?(0) 讚! | 宗室向凝 |
作者: 宗室向凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-06 08:30:27 評論於 Do you need to pay layout fees?(0) 讚! | 宗室向凝 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 19:54:45 評論於 3 points edge, hoping to remain stable, a slight increase is also good(0) 讚! | 凌霄高洁 |
作者: 风见修永 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-03 16:59:39 評論於 But the review process takes too long, I need this article to graduate soon, it seems like I can't submit it(0) 讚! | 风见修永 |
作者: 神古苑博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-01 11:35:28 評論於 Agree with this opinion! Osteoporosis is more popular. Chinese people published 3 papers in 2012, 4 in 2013, and it increased to 12 in 2014, very fast!(0) 讚! | 神古苑博 |
作者: 风见修永 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-01 08:06:55 評論於 Do you have any experience submitting articles in recent years?(0) 讚! | 风见修永 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us